CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 133 filers reported holding CYTOKINETICS INC in Q2 2019. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,032,000 | -58.1% | 41,935 | -60.5% | 0.00% | -50.0% |
| Q4 2021 | $4,844,000 | +125.7% | 106,281 | +15.2% | 0.00% | +100.0% |
| Q1 2021 | $2,146,000 | +102.8% | 92,247 | +81.2% | 0.00% | +100.0% |
| Q4 2020 | $1,058,000 | -8.5% | 50,918 | +3.9% | 0.00% | 0.0% |
| Q2 2020 | $1,156,000 | +194.9% | 49,028 | +47.6% | 0.00% | 0.0% |
| Q1 2020 | $392,000 | -86.4% | 33,225 | -87.8% | 0.00% | -66.7% |
| Q4 2019 | $2,891,000 | +528.5% | 272,550 | +574.0% | 0.00% | +200.0% |
| Q3 2019 | $460,000 | -48.3% | 40,437 | -48.8% | 0.00% | 0.0% |
| Q2 2019 | $889,000 | -47.0% | 78,994 | -61.9% | 0.00% | -50.0% |
| Q1 2019 | $1,676,000 | +41.7% | 207,239 | +10.8% | 0.00% | 0.0% |
| Q4 2018 | $1,183,000 | -4.5% | 187,083 | +48.8% | 0.00% | +100.0% |
| Q3 2018 | $1,239,000 | +25.7% | 125,739 | +5.9% | 0.00% | 0.0% |
| Q2 2018 | $986,000 | +32.3% | 118,751 | +14.9% | 0.00% | 0.0% |
| Q1 2018 | $745,000 | -0.9% | 103,358 | +12.1% | 0.00% | 0.0% |
| Q4 2017 | $752,000 | -64.4% | 92,226 | -36.7% | 0.00% | -66.7% |
| Q3 2017 | $2,112,000 | -14.5% | 145,666 | -28.6% | 0.00% | -25.0% |
| Q2 2017 | $2,469,000 | +14.9% | 204,045 | +22.1% | 0.00% | 0.0% |
| Q1 2017 | $2,148,000 | -30.3% | 167,102 | -34.1% | 0.00% | -20.0% |
| Q4 2016 | $3,080,000 | +7.9% | 253,520 | -18.5% | 0.01% | 0.0% |
| Q3 2016 | $2,855,000 | -1.3% | 310,959 | +2.1% | 0.01% | 0.0% |
| Q2 2016 | $2,892,000 | +33.9% | 304,680 | -0.6% | 0.01% | +25.0% |
| Q1 2016 | $2,160,000 | -46.3% | 306,426 | -20.3% | 0.00% | -33.3% |
| Q4 2015 | $4,022,000 | +26.4% | 384,540 | -19.1% | 0.01% | +20.0% |
| Q3 2015 | $3,181,000 | -20.4% | 475,592 | -20.0% | 0.01% | -16.7% |
| Q2 2015 | $3,995,000 | -19.4% | 594,416 | -18.7% | 0.01% | -25.0% |
| Q1 2015 | $4,959,000 | -33.7% | 731,445 | -21.6% | 0.01% | -20.0% |
| Q4 2014 | $7,476,000 | +125.6% | 933,327 | -0.9% | 0.01% | +150.0% |
| Q3 2014 | $3,314,000 | -17.2% | 941,711 | +12.5% | 0.00% | -20.0% |
| Q2 2014 | $4,003,000 | +3943.4% | 837,349 | +5395.5% | 0.01% | – |
| Q4 2013 | $99,000 | -79.7% | 15,237 | -76.3% | 0.00% | -100.0% |
| Q3 2013 | $487,000 | – | 64,181 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |